HRTX icon

Heron Therapeutics
HRTX

Overview Fund Activity

124 hedge funds and large institutions have $1.25B invested in Heron Therapeutics in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 9 closing their positions.

Holders
124
Holders Change
+20
Holders Change %
+19.23%
% of All Funds
2.82%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
29
Increased
48
Reduced
29
Closed
9
Calls
$14.3M
Puts
$3.32M
Net Calls
+$10.9M
Net Calls Change
+$387K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$174M
2
Citadel Advisors
2
Citadel Advisors
Florida
$28.8M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$128M
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$23.9M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$29.5M

Top Sellers

1
BC
1
Broadfin Capital
New York
$36.7M
2
CC
2
Carlson Capital
Texas
$27.2M
3
CAM
3
Cormorant Asset Management
Massachusetts
$3.62M
4
PA
4
Perceptive Advisors
New York
$0
5
KCM
5
Kingdon Capital Management
New York
$31.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
126
Perceptive Advisors
New York
– -$5.33M -330,000 Closed
GC
127
Guggenheim Capital
Illinois
– -$2.32M -143,840 Closed
NFA
128
Nationwide Fund Advisors
Ohio
– -$406K -25,154 Closed
Norges Bank
129
Norges Bank
Norway
– -$323K -20,000 Closed
T. Rowe Price Associates
130
T. Rowe Price Associates
Maryland
– -$248K -15,327 Closed
QT
131
Quantbot Technologies
New York
– -$103K -6,395 Closed
CG
132
Cutler Group
California
– -$61K -3,816 Closed
PNC Financial Services Group
133
PNC Financial Services Group
Pennsylvania
– -$24K -1,500 Closed
IWM
134
IHT Wealth Management
Illinois
– -$1K -43 Closed
2 3 4 5
6